|
|
1. |
Dienstag JL. Chronic hepatitis. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 19th ed. New York: McGraw-Hill Education; 2015. pp. 2031.
|
|
2. |
Jung JG, Moon DG, Yang HJ, et al. A case of concomitant epstein-barr virus-induced hepatitis on chronic autoimmune hepatitis. Korean J Med 2008;74:658–662.
|
|
3. |
Jacobson IM, Gang DL, Schapiro RH. Epstein-Barr viral hepatitis: an unusual case and review of the literature. Am J Gastroenterol 1984;79:628–632.
|
|
4. |
Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 2006;16:251–261.
|
|
5. |
Rickinson AB. Chronic, symptomatic Epstein-Barr virus infections. Immunol Today 1986;7:13–14.
|
|
6. |
Lee TY, Lee HC, Oh TH, et al. A case of severe chronic active epstein-barr virus infection with hepatic involvement comfirmed by in situ hybridization. Korean J Hepatol 2001;7:195–200.
|
|
7. |
Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481–492.
|
|
8. |
Okano M, Gross TG. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection. Am J Med Sci 2012;343:483–489.
|
|
9. |
Horwitz CA, Henle W, Henle G, Schmitz H. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med 1975;58:330–338.
|
|
10. |
Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 1991;4:129–135.
|
|
11. |
Okano M. Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome. Crit Rev Oncol Hematol 2002;44:273–282.
|
|
12. |
Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005;80:64–69.
|
|
13. |
Drebber U, Kasper HU, Krupacz J, et al. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol 2006;44:879–885.
|
|
14. |
Cohen JI. Optimal treatment for chronic active Epstein-Barr virus disease. Pediatr Transplant 2009;13:393–396.
|
|
15. |
Kurtzman G, Young N. Viruses and bone marrow failure. Baillieres Clin Haematol 1989;2:51–67.
|
|
16. |
Kook H. Aplastic anemia. J Korean Med Assoc 2006;49:885–896.
|
|
17. |
Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003;187:527–533.
|
|